Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition...

Area of Science:

• Oncology
• Computational Biology
• Genomics

Background:

• Predicting kinase dependency in cancer is crucial for targeted therapy but challenging due to complex biological factors.
• Gene expression and mutation status do not always correlate with kinase dependency.
• High-throughput drug screens offer insights but can be complicated by drug polypharmacology.

Purpose of the Study:

• To develop and validate an algorithm, Kinase Addiction Ranker (KAR), for accurately predicting kinase dependency in cancer cells.
• To integrate diverse datasets including drug screening, kinase inhibition, and gene expression profiles.
• To overcome limitations in predicting therapeutic targets for personalized cancer treatment.

Main Methods:

• Developed the Kinase Addiction Ranker (KAR) algorithm.
• Integrated high-throughput drug screening data, comprehensive kinase inhibition data, and gene expression profiles.
• Applied KAR to lung cancer cell lines and leukemia patient samples using published datasets.

Main Results:

• KAR successfully predicted kinase dependency in 21 lung cancer cell lines and 151 leukemia patient samples.
• Experimental validation in H1581 lung cancer cells confirmed KAR's prediction of FGFR and MTOR dependence.
• Combined treatment with ponatinib and AZD8055 showed synergistic reduction in proliferation, validating KAR's predictions.

Conclusions:

• KAR is a robust algorithm for identifying kinase dependency in cancer.
• The algorithm integrates multiple data types to enhance prediction accuracy.
• KAR facilitates personalized cancer therapy by accurately predicting kinase dependencies.